Skip to main content
Clinical Trials/NCT05689190
NCT05689190
Recruiting
N/A

Non-invasive Flow Measurements in Patients With Lower Extremity Arterial Disease (LEAD)

Philips Clinical & Medical Affairs Global1 site in 1 country30 target enrollmentApril 25, 2023

Overview

Phase
N/A
Intervention
Not specified
Conditions
Lower Extremity Arterial Disease
Sponsor
Philips Clinical & Medical Affairs Global
Enrollment
30
Locations
1
Primary Endpoint
blood flow
Status
Recruiting
Last Updated
5 months ago

Overview

Brief Summary

This concerns a study with patients who will undergo endovascular treatment. Blood flow will be measured by 2D Duplex Ultrasound. Contrast data will be collected that will be processed offline.

Registry
clinicaltrials.gov
Start Date
April 25, 2023
End Date
March 31, 2026
Last Updated
5 months ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Patients referred to the vascular surgery outpatient clinic (LUMC) with PAD
  • Age ≥18 years
  • Superficial femoral artery (SFA) stenosis (\>70% occluded)
  • Elective for a percutaneous transluminal angioplasty procedure
  • Written informed consent

Exclusion Criteria

  • Contraindications to angiography, such as severe renal insufficiency (eGFR\< 20)
  • Non-correctable bleeding disorder.

Outcomes

Primary Outcomes

blood flow

Time Frame: performed during a regular PTA intervention

Repeatability and correlation of angiographic hemodynamic measurements compared with the golden standard 2D duplex ultrasound.

Study Sites (1)

Loading locations...

Similar Trials